Kanta Chandwe1, Beatrice Amadi1, Miyoba Chipunza1, Masuzyo Zyambo2, Paul Kelly1,3. 1. Tropical Gastroenterology & Nutrition group, University of Zambia School of Medicine, 10101 Lusaka, Zambia. 2. Department of Anaesthesia, University of Zambia School of Medicine, 10101 Lusaka, Zambia. 3. Barts & The London School of Medicine, Queen Mary University of London, London E1 2AT, UK.
Abstract
BACKGROUND: Environmental enteropathy is an example of a poorly-understood intestinal disorder affecting millions of children worldwide, characterized by malabsorption and stunting. Although there is increasing interest in non-invasive means of assessing intestinal structure and function, the potential value of intestinal biopsy for histology, immunostaining, RNA sequencing and epigenetic work means that endoscopic biopsy remains extremely valuable. We here report our experience in the BEECH (Biomarkers of Environmental Enteropathy in CHildren) study of stunting in Zambia, in the belief that it may help address the knowledge gap regarding the safety of endoscopic biopsy in vulnerable young children. METHODS: We report our experience of safety in 119 children undergoing endoscopic biopsy in the BEECH study in Lusaka Children's Hospital, Lusaka, and discuss ethical considerations in this light. RESULTS: Upper gastrointestinal endoscopy was performed on children with stunting (length-for-age z score -2 or less) not responsive to nutritional interventions. Conscious sedation was provided by anaesthetists. Of 119 children, 5 (4%) developed transient desaturation, but no serious adverse events were experienced; no clinical, demographic or anaesthetic characteristics were identified as predictive of desaturation. Two children derived clinically useful information from the endoscopy, one life-saving. Of 105 lactase tests, 59 (54%) showed hypolactasia. DISCUSSION: Children with stunting underwent endoscopy safely, and some derived clinical benefit. Safety and the possibility of clinical benefit are usually felt to be preconditions for the ethical justification for endoscopy for research in children, and we believe that these conditions were met in this study.
BACKGROUND: Environmental enteropathy is an example of a poorly-understood intestinal disorder affecting millions of children worldwide, characterized by malabsorption and stunting. Although there is increasing interest in non-invasive means of assessing intestinal structure and function, the potential value of intestinal biopsy for histology, immunostaining, RNA sequencing and epigenetic work means that endoscopic biopsy remains extremely valuable. We here report our experience in the BEECH (Biomarkers of Environmental Enteropathy in CHildren) study of stunting in Zambia, in the belief that it may help address the knowledge gap regarding the safety of endoscopic biopsy in vulnerable young children. METHODS: We report our experience of safety in 119 children undergoing endoscopic biopsy in the BEECH study in Lusaka Children's Hospital, Lusaka, and discuss ethical considerations in this light. RESULTS: Upper gastrointestinal endoscopy was performed on children with stunting (length-for-age z score -2 or less) not responsive to nutritional interventions. Conscious sedation was provided by anaesthetists. Of 119 children, 5 (4%) developed transient desaturation, but no serious adverse events were experienced; no clinical, demographic or anaesthetic characteristics were identified as predictive of desaturation. Two children derived clinically useful information from the endoscopy, one life-saving. Of 105 lactase tests, 59 (54%) showed hypolactasia. DISCUSSION: Children with stunting underwent endoscopy safely, and some derived clinical benefit. Safety and the possibility of clinical benefit are usually felt to be preconditions for the ethical justification for endoscopy for research in children, and we believe that these conditions were met in this study.
Authors: Simon Murch; Huw Jenkins; Marcus Auth; Ronald Bremner; Assad Butt; Stephanie France; Mark Furman; Peter Gillett; Fevronia Kiparissi; Maureen Lawson; Bruce McLain; Mary-Anne Morris; Sarah Sleet; Matthew Thorpe Journal: Arch Dis Child Date: 2013-08-28 Impact factor: 3.791
Authors: Beatrice Amadi; Andrew O Fagbemi; Paul Kelly; Mwiya Mwiya; Franco Torrente; Camilla Salvestrini; Richard Day; Michael H Golden; Erik A Eklund; Hudson H Freeze; Simon H Murch Journal: Am J Clin Nutr Date: 2008-12-30 Impact factor: 7.045
Authors: Beatrice Amadi; Ellen Besa; Kanekwa Zyambo; Patrick Kaonga; John Louis-Auguste; Kanta Chandwe; Phillip I Tarr; Donna M Denno; James P Nataro; William Faubion; Anne Sailer; Sunil Yeruva; Tricia Brantner; Joseph Murray; Andrew J Prendergast; Jerrold R Turner; Paul Kelly Journal: EBioMedicine Date: 2017-07-19 Impact factor: 11.205
Authors: Clair Null; Christine P Stewart; Amy J Pickering; Holly N Dentz; Benjamin F Arnold; Charles D Arnold; Jade Benjamin-Chung; Thomas Clasen; Kathryn G Dewey; Lia C H Fernald; Alan E Hubbard; Patricia Kariger; Audrie Lin; Stephen P Luby; Andrew Mertens; Sammy M Njenga; Geoffrey Nyambane; Pavani K Ram; John M Colford Journal: Lancet Glob Health Date: 2018-01-29 Impact factor: 26.763
Authors: Kanta Chandwe; Kanekwa Zyambo; Chola Mulenga; Talin Haritunians; Beatrice Amadi; Margaret Kosek; Douglas C Heimburger; Dermot McGovern; Paul Kelly Journal: J Pediatr Gastroenterol Nutr Date: 2021-10-28 Impact factor: 3.288
Authors: Chola Mulenga; Sanja Sviben; Kanta Chandwe; Beatrice Amadi; Violet Kayamba; James A J Fitzpatrick; Victor Mudenda; Paul Kelly Journal: Front Med (Lausanne) Date: 2022-03-16